Stocks / CRL vs OSCR

CRL vs OSCR

Charles River Laboratories International, Inc. and Oscar Health, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

CRL is the larger company ($8.8B vs $8.5B). On the fundamentals, OSCR grows revenue faster (90.8% vs 6.5%); CRL earns a higher net margin (-3.6% vs -3.8%); CRL has the stronger return on equity (-4.6% vs -45.3%). Full numbers below — the stronger figure on each row is in green.

	Charles River Laboratories International, Inc. (CRL)	Oscar Health, Inc. (OSCR)
Market cap	$8.8B	$8.5B
Revenue (latest FY)	$4.02B	$11.70B
Net income (latest FY)	$-144.34M	$-443.15M
Revenue growth (5y CAGR)	6.5%	90.8%
Net margin	-3.6%	-3.8%
Return on equity	-4.6%	-45.3%
P/E ratio	—	—
Dividend yield	—	—
Profitable years (of last 10)	9	1
Positive free cash flow	Yes	Yes

Compare with another company:

See the full CRL vs OSCR breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open CRL's full financials → Open OSCR's full financials →

More comparisons

CRL vs ENSG HALO vs OSCR CRL vs TEM BRKR vs OSCR CRL vs TECH OSCR vs UHS CRL vs UHS CORT vs OSCR

Frequently asked questions

Which is bigger, CRL or OSCR?

Charles River Laboratories International, Inc. is larger by market capitalization — $8.8B versus $8.5B.

Which grows faster, CRL or OSCR?

Over the last five fiscal years, Oscar Health, Inc. grew revenue faster — 90.8%/yr versus 6.5%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

Fastest-growing stocks →

CRL fundamentals → · OSCR fundamentals → · All 1,500+ companies → · Free screener →